HAX News

SOSV Raises $277 Million In Oversubscribed Fourth Fund To Invest In Early-Stage Deep Tech Startups

SOSV IV fund will allow the firm to continue its strategy to invest an initial $100k to $250k in each startup via its programs, while providing $200k to $2 million in follow-on funding in subsequent rounds for startups which go through its programs
Cyril Ebersweiler


December 11, 2019

(SAN FRANCISCO, December 11, 2019, 9am PST) — SOSV has raised $277 million for its new SOSV IV fund, nearly doubling its previous $150 million SOSV III fund. SOSV, known for investing in deep-tech, is often ranked as the most active investor in startups in hardware and life sciences.

With SOSV IV, the firm will continue investing in approximately 150 new startups per year across its industry-leading accelerator programs HAX, IndieBio, RebelBio, Chinaccelerator, MOX, Food-X, and dlab. The majority of the fund will be deployed in the later rounds of its best performers.

“This year nearly $1 billion went into SOSV-backed companies from VCs and corporate investors,” said Sean O’Sullivan, SOSV Managing Partner. “On top of the $65 million SOSV invests directly into our startups every year, SOSV’s deep-tech startups are getting huge funding leverage from our syndicate of VCs, angels and corporates.”

Solving Global Challenges With Hands-On Support

The larger SOSV IV fund will allow the firm to continue its strategy to invest an initial $100k to $250k in each startup via its accelerator programs, while providing $200k to $2 million in follow-on funding in subsequent rounds for startups which go through its programs.

SOSV invests over ten million dollars annually in infrastructure — building out and running wet labs, electronic labs, and mechanical facilities, and offering on-site support teams of dozens of experts, engineers and PhDs. These program benefits help startups with accelerated product development and increased access to an ecosystem of corporations, investors and over 1,000 specialized mentors.

“In the early 2000s, investors could not fund hardware and life sciences startups in the same incremental and iterative way as software. In 2020 and beyond, the majority of deep tech startups can now follow a lean model,” said O’Sullivan. “Our hands-on approach has helped hundreds of startups overcome the challenges of going from workshop or lab to the market.”

The programs run by SOSV employ over 100 staff distributed across nine locations in San Francisco, New York, Cork, London, Shenzhen, Shanghai, Xi’An, Taipei, and Tokyo.

Select Portfolio Highlights

On the life sciences front, SOSV invests in human and planetary health as an early investor in plant-based foods, cellular agriculture, computational biology and regenerative medicine. In hardware, the firm is an early mover in applied A.I., service robotics, industrial IoT, and digital therapeutics.

SOSV helps deep tech startups go from lab to market

Its hardware-enabled portfolio includes fast-growing robotics, IoT and medtech startups such as Avidbots (commercial cleaning robots), Simbe Robotics (retail inventory robots), Particle (IoT solutions) and Makeblock (STEM robots), as well as high-profile companies FormLabs (3D printing) and GetAround (car sharing). SOSV was also the lead seed investor in JUMP Bikes, recently acquired by Uber.

SOSV is a pioneer in ‘clean food’ and cellular agriculture with investments in Memphis Meats (clean meat), NotCo (plant-based mayonnaise) Geltor (animal-free collagen), Clara Foods (egg proteins), Perfect Day (milk products), and Abbot’s Butcher (plant-based meat). SOSV was the initial investor in Jungla (A.I.-driven genomics), acquired in July 2019 by Invitae (Nasdaq: NVTA).

Therapeutics has always been the core application of biotech, and SOSV has remained one of the industry’s most active funds, investing in cancer therapeutics (Synthex, Filtricine, A2A Pharma), new modalities for autoimmune diseases (Diadem, DNA Lite), regenerative medicine (Prellis), and gene delivery (Serenity).

In the blockchain and cross-border areas, SOSV is the only institutional investor in BitMEX (the leading cryptocurrency trading platform by reported volume globally), and seed investor in the A.I. insurtech startup CareVoice and the A.I. language startup Elsa (Google’s AI fund’s first investment in Asia).

About the Backers of SOSV IV

The investors participating in SOSV IV include university endowments, foundations, fund of funds, corporates, family offices and wealthy individuals from around the world. Some of the noteworthy limited partners include Tiedemann Advisors, Davy Group, HP Tech Ventures, ZX Ventures (AB Inbev) and Honda Motors. In addition, nine venture capitalists invested either personally or as part of their funds.

About SOSV

SOSV manages over $700 million with a portfolio of over 900 startups. Managing Partner Sean O’Sullivan created the firm in 1995 after the IPO of MapInfo, the startup he co-founded that pioneered street mapping on computers. In 2010, SOSV opened Chinaccelerator, the first accelerator program in China, and was the first to create accelerators in hardware (HAX) and life sciences (IndieBio). Today, the firm has 8 general partners amongst a 110-person staff across eight locations in the US, Europe and Asia.

In both 2018 and 2019, three of SOSV’s startups were selected each year as creators of the Top Inventions of the Year by TIME Magazine, a feat unparalleled by any Fortune 500 company or any other VC.

Cyril Ebersweiler


December 11, 2019
SOSV's HAX is the most active early stage investor in hard tech startups, empowering founders building with robotics, internet of things, digital health, consumer products and industrial technologies. The HAX Program combines hands-on co-development with our experienced product development team, multi-stage venture capital investment, and collaboration with our global founder community building hard tech startups. Since 2012, HAX has invested in over 250 startups meshing hardware and software across its locations in San Francisco, Shenzhen and Tokyo.